Raha Samraat S. bought MYGN
March 9, 2026 · Form 4 insider transaction
Raha Samraat S. bought 40,000 shares of Myriad Genetics, Inc. at $5.00 per share, a transaction worth $199.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$5.00
Total value
$199.8K
InsiderRaha Samraat S.
Role—
CompanyMyriad Genetics, Inc. (MYGN)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 9, 2026
Filing dateMarch 9, 2026
Shares owned after493,104
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.97 to $5.00, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.